Suppr超能文献

24 年内停止驾驶:痴呆严重程度与脑脊液生物标志物。

Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers.

机构信息

Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.

Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

Alzheimers Dement. 2018 May;14(5):610-616. doi: 10.1016/j.jalz.2017.11.011. Epub 2018 Jan 10.

Abstract

INTRODUCTION

With 36 million older adult U.S. drivers, safety is a critical concern, particularly among those with dementia. It is unclear at what stage of Alzheimer's disease (AD) older adults stop driving and whether preclinical AD affects driving cessation.

METHODS

Time to driving cessation was examined based on Clinical Dementia Rating (CDR) and AD cerebrospinal fluid biomarkers. 1795 older adults followed up to 24 years received CDR ratings. A subset (591) had cerebrospinal fluid biomarker measurements and was followed up to 17 years. Differences in CDR and biomarker groups as predictors of time to driving cessation were analyzed using Kaplan-Meier curves and Cox proportional models.

RESULTS

Higher CDR scores and more abnormal biomarker measurements predicted a shorter time to driving cessation.

DISCUSSION

Higher levels of AD biomarkers, including among individuals with preclinical AD, lead to earlier driving cessation. Negative functional outcomes of preclinical AD show a nonbenign phase of the disease.

摘要

简介

美国有 3600 万老年驾驶员,安全是一个关键问题,特别是对于痴呆症患者而言。目前尚不清楚老年人在阿尔茨海默病(AD)的哪个阶段停止驾驶,以及临床前 AD 是否会影响驾驶停止。

方法

根据临床痴呆评定量表(CDR)和 AD 脑脊液生物标志物来检查停止驾驶的时间。1795 名接受随访长达 24 年的老年人接受了 CDR 评分。其中一部分(591 名)进行了脑脊液生物标志物测量,并随访了长达 17 年。使用 Kaplan-Meier 曲线和 Cox 比例模型分析 CDR 和生物标志物组作为预测停止驾驶时间的差异。

结果

更高的 CDR 评分和更多异常的生物标志物测量预示着停止驾驶的时间更短。

讨论

更高水平的 AD 生物标志物,包括在临床前 AD 患者中,导致更早地停止驾驶。临床前 AD 的负面功能结果显示出疾病的非良性阶段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18df/5938126/f1e4255f09bc/nihms929936f1.jpg

相似文献

引用本文的文献

1
Drivers with dementia: Forecasting the future.患有痴呆症的司机:预测未来。
J Alzheimers Dis. 2025 Jul;106(2):756-764. doi: 10.1177/13872877251344873. Epub 2025 Jul 1.
8
Driving Status and Transportation Disadvantage Among Medicare Beneficiaries.医疗保险受益人的驾驶状况和交通劣势。
J Appl Gerontol. 2020 Sep;39(9):935-943. doi: 10.1177/0733464818806834. Epub 2018 Oct 26.

本文引用的文献

6
Spatial Navigation in Preclinical Alzheimer's Disease.临床前阿尔茨海默病中的空间导航
J Alzheimers Dis. 2016 Feb 9;52(1):77-90. doi: 10.3233/JAD-150855.
9
Driving continuity in cognitively impaired older drivers.推动认知障碍老年驾驶员的驾驶连续性。
Geriatr Gerontol Int. 2016 Apr;16(4):508-14. doi: 10.1111/ggi.12504. Epub 2015 May 8.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验